And it depends on you how soon it will be developed
Equities have greeted 2018 with a bang, but none more so than Korean pharmaceutical maker Celltrion Inc., which has piled on about 9 trillion won ($8.4 billion) of market value in just seven days.
On Wednesday, Warren Buffett's Berkshire Hathaway disclosed a $358 million stake in Israeli generic drug company Teva Pharmaceutical Industries.
Young, resting neural stem cells have large protein clumps often associated with neurodegeneration. As stem cells age, the aggregates inhibit their ability to make new neurons, Stanford researchers say.
In 2016, the United States spent nearly twice as much as 10 high-income countries on medical care and performed less well on many population health outcomes.